Healthline
December 6, 2025
Share on PinterestAccording to the latest research, plant-based diets may help prevent a range of chronic conditions, including diabetes. Image credit: Monica Bertolazzi/Getty Images Research shows […]
December 5, 2025
Share on Pinterest Doctors are raising concerns that the move to delay the hepatitis B shot for newborns upends decades of vaccination policy without evidence and […]
December 4, 2025
Share on PinterestA nationwide recall of shredded cheese products that may contain metal fragments raises concern over the possible risks of intestinal injury or illness. Luciano […]
December 3, 2025
Share on PinterestThe risk of “scromiting” increases with chronic cannabis use, especially daily use. Maskot/Getty Images A vomiting disorder linked to chronic cannabis use, known colloquially […]
Medscape
July 8, 2025
Obesity often brings about, or exacerbates, depression and anxiety. Yet some of the most effective drugs for managing depression are also known to cause weight gain. […]
July 8, 2025
Despite dramatic treatment advances in recent years, the dermatology community has lacked a unified definition for what remission means in plaque psoriasis. Now, a multistage Delphi […]
July 8, 2025
Could a simple advisory or alert in the electronic medical record (EMR) be the key to more frequent diagnosis and effective treatment of high blood pressure […]
July 8, 2025
In young children, the long-term effects of SARS-CoV-2 infection may differ significantly from those in older children or adults. A recent study in JAMA Pediatrics systematically […]
FDA
December 5, 2025
Reports Mandated by FDORA The Food and Drug Omnibus Reform Act of 2022 (FDORA) requires FDA to develop several different kinds of informational documents, including public […]
December 4, 2025
On December 4, 2025, the Food and Drug Administration approved lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company) for adults with relapsed or refractory […]
December 4, 2025
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this […]
December 3, 2025
On December 3, 2025, the Food and Drug Administration granted traditional approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for adults with relapsed or refractory chronic […]
